All diseases

Disease Atlas / Disease detail

Ebola disease

An evidence-led atlas of orthoebolavirus exposure, isolation and high-risk diagnosis, intensive support, and species-specific therapeutics.

Ebola hemorrhagic fever · Ebola disease · Ebola virus disease

MONDO:0005737Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · 3a0c5011f28d

Disease class
Ebola disease results from infection with one of the orthoebolaviruses known to cause human disease.
Core mechanism
After initial animal-to-human transmission, it can spread by direct contact with infected blood, body fluids, or contaminated materials.
Genes or cause
People are generally not infectious before symptoms begin.
Typical features
Fever, severe fatigue, myalgia, headache, and sore throat may be followed by vomiting, diarrhea, rash, and organ dysfunction.
Variability
Bleeding can occur but is not a required feature in every patient.
Diagnosis
Diagnosis assesses compatible exposure and symptoms and is confirmed with specialized tests such as RT-PCR.
Management
Non-inactivated specimens pose extreme biohazard risk and require designated packaging, transport, and testing procedures.
Treatment and research
Suspected cases require immediate public-health coordination and evaluation under appropriate PPE and infection control.
Reading evidence
Early intensive supportive care includes fluids and electrolytes, oxygen, blood-pressure support, and management of pain, vomiting, and diarrhea.
Key caution
Approved monoclonal-antibody treatments exist for Zaire ebolavirus disease, but the same approvals do not extend to other species.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a glance

Ebola disease results from infection with one of the orthoebolaviruses known to cause human disease.

Fever, severe fatigue, myalgia, headache, and sore throat may be followed by vomiting, diarrhea, rash, and organ dysfunction.

How the disease works

After initial animal-to-human transmission, it can spread by direct contact with infected blood, body fluids, or contaminated materials.

People are generally not infectious before symptoms begin.

Why experiences vary

Bleeding can occur but is not a required feature in every patient.

Diagnosis and management

Diagnosis assesses compatible exposure and symptoms and is confirmed with specialized tests such as RT-PCR.

Treatment status

Non-inactivated specimens pose extreme biohazard risk and require designated packaging, transport, and testing procedures.

Suspected cases require immediate public-health coordination and evaluation under appropriate PPE and infection control.

Reading clinical trials

Virus can persist in some body fluids after recovery, requiring survivor follow-up and transmission-prevention counseling.

Topics for a clinical visit

Clinical discussion should cover exact exposure, symptom onset, isolation and testing procedures, virus species, and supportive and specific therapy.

Medical notice

This material is for disease education and is not a personal diagnosis or treatment instruction.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.